Loading the section…

NHC: financial statements from SEC — TradeAlmanac

NHC

National HealthCare Corporation: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Revenue	382M	383M	375M	374M	340M	301M
Operating expenses	350M	352M	341M	343M	317M	278M
Operating income	32M	30M	34M	31M	23M	23M
Interest expense	—	—	—	—	2M	0
Pre-tax income	45M	54M	32M	44M	58M	37M
Income tax	9M	13M	8M	11M	15M	9M
Net income	36M	39M	24M	32M	43M	27M
Earnings per share	2.31	2.53	1.53	2.09	2.78	1.74
Earnings per share, diluted	2.27	2.50	1.52	2.07	2.73	1.73
Weighted average shares	16M	15M	15M	15M	15M	15M
Weighted average shares, diluted	16M	16M	16M	16M	16M	16M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	86M	93M	131M	111M	90M	76M	85M	136M
Receivables	138M	139M	132M

Cash flow

Metric	31/03/2026	30/09/2025	30/06/2025	31/03/2025	30/09/2024	30/06/2024
Operating cash flow	63M	—	—	39M	—	—
Depreciation and amortisation	12M	11M	11M	11M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator